XENE
Xenon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.42 / 10Overall Score
NeturalInvestment Rating
4.42 / 10Overall Score
NeturalInvestment Rating
Is XENE a Buy, Sell, or Hold?
- Based on a composite score of 4.42/10, we rate XENE as a Netural. Our analysis breaks down into 4.24/10 for Fundamentals, 3.56/10 for Technicals, and 4.95/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of XENE?
Is XENE undervalued or overvalued?
What is the analyst consensus for XENE?
Is XENE a Buy, Sell, or Hold?
- Based on a composite score of 4.42/10, we rate XENE as a Netural. Our analysis breaks down into 4.24/10 for Fundamentals, 3.56/10 for Technicals, and 4.95/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is XENE undervalued or overvalued?
Technical Analysis of XENE?
What is the analyst consensus for XENE?
